1Schiller JH, Harington D, Belanie CP, et al. Compmison of four chemotherapy regimens for advanced non small call lung cancer [J]. New Eng J Med , 2002,346 (2) :92-98. 被引量：1
6Ranson M.Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer[J].J Natl Cancer Inst,2000,92(13):1074-1080. 被引量：1
7Prudence AF,James RR,Mark GK,et al.Phase Ⅱ trial of docetaxel in patients with stage Ⅲ and Ⅳ non-small cell lung cancer[J].J Clin Oncol,1994,12(6):1232-1237. 被引量：1
8Georgoulias V,Ardavanis A,Agelidou A,et al.Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small lung cancer:a randomized,multicenter phase Ⅲ trial[J].J Clin Oncol,2004,22(13):2602-2609. 被引量：1
9Belani CP,Fossella F.Elderly subgroup analysis of a randomized phase Ⅲ study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced non small cell lung carcinoma (TAX326)[J].Cancer,2005,104(12):2766-2774. 被引量：1
10Cesare Gridelli,Frances A.Shepherd.Chemotherapy for elderly patients with non-small cell lung cancer:A review of the evidence[J].Chest,2005,128(2):947-957. 被引量：1
